Skip to content
20-F/A

Annual Report (Foreign)

EMPOWER CLINICS INC.

0001654954-21-002126

← back to feed
Filed
Feb 26, 2021 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2018 · Dec 31, 2018 77.85M sh
Current Liabilities FY 2018 · Dec 31, 2018 $3.26M
Current Liabilities restated FY 2018 · Dec 31, 2017 $5.44M
Total Liabilities FY 2018 · Dec 31, 2018 $3.51M
Total Liabilities restated FY 2018 · Dec 31, 2017 $5.44M
Current Assets FY 2018 · Dec 31, 2018 $187.14K
Current Assets restated FY 2018 · Dec 31, 2017 $158.63K
Total Assets FY 2018 · Dec 31, 2018 $513.79K
Total Assets FY 2018 · Dec 31, 2017 $629.8K
Shares Diluted FY 2018 · Dec 31, 2017 48.07M sh
Shares Diluted FY 2018 · Dec 31, 2016 11.75M sh
Operating Cash Flow restated FY 2018 · Dec 31, 2017 −$1.59M
Operating Cash Flow restated FY 2018 · Dec 31, 2016 −$523.83K
Eps Diluted FY 2018 · Dec 31, 2017 −$0.06
Eps Diluted FY 2018 · Dec 31, 2016 −$0.14
Eps Basic FY 2018 · Dec 31, 2017 −$0.06
Eps Basic FY 2018 · Dec 31, 2016 −$0.14
Net Income restated FY 2018 · Dec 31, 2017 −$3.11M
Net Income restated FY 2018 · Dec 31, 2016 −$1.59M
Gross Profit FY 2018 · Dec 31, 2017 $868.22K
Gross Profit FY 2018 · Dec 31, 2016 $1.42M
Revenue FY 2018 · Dec 31, 2017 $1.51M
Revenue FY 2018 · Dec 31, 2016 $2.13M
Cash And Equivalents restated FY 2018 · Dec 31, 2016 $5.15K
Cash And Equivalents restated FY 2018 · Dec 31, 2015 $6.91K
Stockholders Equity restated FY 2018 · Dec 31, 2016 −$1.88M
Stockholders Equity restated FY 2018 · Dec 31, 2015 −$877.71K